Author:
Burden A. David,Kirby Brian
Abstract
AbstractPsoriasis encompasses a group of related immune‐mediated inflammatory skin diseases that affect up to 3% of the population. These diseases are heritable and over 40 genetic susceptibility loci have been identified, many of which are involved in antigen presentation, cytokine signalling or innate antimicrobial responses. The commonest presentation of psoriasis is plaque psoriasis but the disease is clinically hetereogeneous in its manifestations and natural history depending on the age of the patient, environmental triggers and the sites affected. Distinct but related phenotypes include psoriatic arthritis, palmoplantar pustulosis and generalized pustular psoriasis. Psoriasis is associated with co‐morbidities including obesity, diabetes, vascular disease, depression and inflammatory bowel disease, which contribute to the considerable morbidity and increased mortality. Treatments include topical agents for disease of limited extent, phototherapy (UVB, PUVA) and systemic therapy (methotrexate, ciclosporin, acitretin, fumarates) for more extensive disease, and biological treatment (tumour necrosis factor α inhibitors, ustekinumab) for severe resistant psoriasis.
Reference804 articles.
1. National Institute for Health and Care Excellence (NICE) guideline 2012. The assessment and management of psoriasis. Clinical Guideline. Methods evidence and recommendations. NICE 2012.http://www.nice.org.uk/Cg153
2. Scottish Intercollegiate Guidelines Network (SIGN) guideline. Diagnosis and management of psoriasis in adults.http://www.sign.ac.uk/guidelines/fulltext/121/
3. www.psoriasis‐association.org.uk
4. http://www.papaa.org
5. http://www.irishskinfoundation.ie
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献